Identification of a novel signature based on M6a modification regulators related LncRNA for stratification of the prognosis of prostate cancer.

Prostate cancer emerges as a life-threatening disease that affects approximately 1.3 million patients of male population globally. Various studies established lncRNAs as a critical role in prostate cancer progression by regulating multiple epigenetic pathways.